Skip to main content
. 2021 Oct 26;15:732648. doi: 10.3389/fnhum.2021.732648

Table 3.

Quality assessment of included studies.

graphic file with name fnhum-15-732648-i0001.jpg Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14
Klamroth et al. (2016) 1 1 1 0 0 1 1 1 1 ? 1 0 1 1
Shen and Mak (2015) 1 1 1 0 1 1 0 1 1 ? 1 1 ? 0
Cakit et al. (2007) 1 ? ? ? 1 1 0 0 1 ? 1 0 ? 0
Gimmon et al. (2018) 1 1 ? ? ? 0 0 1 ? ? 1 1 1 ?
Steib et al. (2017) 1 1 1 0 1 1 0 1 1 1 1 0 1 0
Rieger et al. (2020) 1 ? ? ? ? 1 1 1 ? ? 1 0 ? 1
Harro et al. (2014a) 1 ? ? 0 1 1 1 1 1 ? 1 1 ? 1
Martelli et al. (2017) ? ? 1 1 ? 1 0 ? 1
Sum score 7/7 4/7 3/7 0/8 4/8 7/8 3/7 6/7 6/8 1/8 8/8 3/8 3/8 4/8

Green color: low risk of bias, Red color: high risk of bias, Orange color: not reported, Dark gray color: not applicable. Q1: RCT, no/RCT, Q2: randomization quality, Q3: concealed allocation, Q4: participant blinding, Q5: blinded testers, Q6: similar groups, Q7: drop-out <20%, Q8: differential drop-out rate <15%, Q9: adherence >75%, Q10: similar background treatments, Q11: valid outcome measures, Q12: power >80%, Q13: preregistration, Q14: intention-to-treat.